Christina Dixon
Adult Health · Rockingham, NCNPI 1497039911
Payments from drug & device makers
Across 202 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$1K
- Forte Bio-pharma LLC$1K
- Collegium Pharmaceutical, Inc.$581
- Hikma Pharmaceuticals USA$165
- Vertex$158
- AbbVie$89
- plus $214 from 7 others
What the payments were for
- Food & beverage$3,61898%
- Education$842%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 74 | $1,340 |
| Forte Bio-pharma LLC | 54 | $1,156 |
| Collegium Pharmaceutical, Inc. | 41 | $581 |
| Hikma Pharmaceuticals USA | 11 | $165 |
| Vertex | 6 | $158 |
| AbbVie | 4 | $89 |
| Redhill Biopharma Inc. | 2 | $48 |
| Boston Scientific | 2 | $39 |
| Virtus Pharmaceuticals LLC | 2 | $33 |
| IBSA Pharma Inc. | 2 | $27 |
| Abbott | 1 | $27 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,702 in reported general payments places this provider in the 85th percentile of 614 adult health providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,236 | $375,636 |
| ZtlidoLidocaine | 152 | $158,825 |
| BelbucaBuprenorphine Hcl | 79 | $72,380 |
| Xtampza ErOxycodone Myristate | 97 | $52,114 |
| Buprenorphine | 78 | $27,533 |
| LinzessLinaclotide | 36 | $19,539 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 621 | $17,137 |
| Lidocaine | 48 | $9,694 |
| Oxycodone Hcl | 532 | $9,674 |
| Gabapentin | 551 | $6,409 |
| MovantikNaloxegol Oxalate | 13 | $5,449 |
| Pregabalin | 356 | $4,684 |
| Diclofenac Sodium | 76 | $3,149 |
| Naloxone Hcl | 33 | $2,274 |
| Morphine Sulfate ErMorphine Sulfate | 50 | $1,660 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Ztlido | $1,340 | $158,825152 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $581 | $124,494176 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $165 | $28,426110 claims |
| AbbVieLinzess | $89 | $19,53936 claims |
| Redhill Biopharma Inc.Movantik | $48 | $5,44913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 614 adult health providers in North Carolina.
Other adult health in Rockingham
- Heather FutrellRockingham$8K
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
- Anna BooneReidsville$51K
- Chaely MedleyChapel Hill$47K
- Ann ShumDurham$35K
- Amy HopkinsGreenville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.